|
Latest Twitter Posts for "Biotechnology" |
|
Recent Police Force News:
New Report Examines the Key to Success in Drug and Device Collaborations
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a report on bio-device licensing which assesses the critical success factors in drug and device collaborations.
Courses in Biotechnology
Biotechnology has come up as a very promising career option in India as well as abroad in the past decade. Owing to this, a lot of students with an interest in sciences and research opt for courses in biotechnology to take it up as a profession. As the term suggests, it is a combination of biology and technology. It is a knowledge-based industry that relies on human skills to leverage existing technology, scientific methods and knowledge of biology to come up with products and solutions to everyday situations of life as well as many other fields that affect us like medicine, agriculture, environment, genetics, industrial growth etc. In biotechnology, technology is applied on biological systems, living organisms, and enzymes to perform indus ...
Johns Hopkins to Unveil Center for Biotechnology Education
The Johns Hopkins University’s Zanvyl Krieger School of Arts and Sciences, Advanced Academic Programs, will unveil the Center for Biotechnology Education () on Thursday, May 13, at its fifth annual biotechnology research symposium, from 5:30 to 8:30 p.m. in Gilchrest Hall on the Montgomery County campus, 9601 Medical Center Drive in Rockville.
National Push Needed for Better Utilization of Seafood Byproducts
Strategro offers vision for better utilization of seafood byproduct materials and details critical weaknesses of current situation, at Pacific Rim Summit on Industrial Biotechnology and Bioenergy, held recently in Vancouver, BC.
BIO Lauds House of Representatives' Vote to Reform SBIR Program: Changes Mean Additional Funding for Biotechnology Research
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement today lauding Members of the House of Representatives for reauthorizing the Small Business Innovation Research (SBIR) program (368-43), with provisions that allow more biotechnology companies to compete for research funding:
The Outbreak Of The Biopharmaceutical Industry Monoclonal Antibody Opportunity
Now what is called the medical milestone drug use, so do not worry about cancer patients during chemotherapy, along with the bad cells with good cell was killed. As a result, most patients can reduce pain, increase the probability of cure. For such patients is nothing less than "good news" of medicine is: monoclonal antibody drugs.
adultstemcell.org
The Adult Stem Cell Forum
